PATENT CLAIM ANALYSIS

Application Number: 16001781
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["800", "024000"]

Abstract:
Immunocompatible pluripotent stem cells (pSCs), which include cells compatible with different patient populations or patient-specific cells, find wide application in regenerative medicine therapies. Described herein are immunocompatible pSCs generated using techniques such as parthenogenesis resulting in cells possessing desired haplotypes of reduced zygosity, antigenically compatible with multiple patient populations, or nuclear transfer allowing generation of patient-specific cells. Methods described herein related to parthenogenesis, nuclear transfer, or pSC cell line generation. Also described herein are compositions of immunocompatible pSCs and cell lines generated by the aforementioned techniques.

Claim (Index 16):
The method of  claim 12 , wherein the donor cell comprises a somatic cell or germ cell.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.58065
- Patent Class: 800.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14180825', '14276810', '13352252', '12122557', '13316199']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6587984154925187
- 35 USC 102 Novelty (BERT): 0.5780877865666174
- Combined Prediction Score: 0.6507273525999286
- Mean Citation Score: 384.091276
- Max Citation Score: 625.93286
- Similarity Product: 384.1548644835114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test